- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 102,900 | 30.09.24 17:35:42 | -0,340 | -0,33% | 0,000 | 0,000 | 103,400 | 103,240 |
|
Regeneron Pharmaceuticals | 881535 | NASDAQ | 1.051,170 | 30.09.24 21:41:58 | +8,480 | +0,81% | 1.050,500 | 1.052,320 | 1.040,730 | 1.042,690 |
